AIRSUPRA® (albuterol/budesonide) now available as the ... - AstraZeneca US
2024年1月22日 · It is an inhaled, fixed-dose combination rescue medication containing albuterol (also known as salbutamol), a SABA, and budesonide, a corticosteroid, and has been developed in a pMDI using AstraZeneca’s Aerosphere delivery technology.
PULMICORT FLEXHALER® (budesonide inhalation powder) - AstraZeneca …
This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.
Asthma & COPD Treatment | SYMBICORT® (budesonide…
Official patient website for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects.
PULMICORT RESPULES® (budesonide inhalation suspension) - AstraZeneca …
This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.
Airsupra (PT027) approved in the US for asthma - AstraZeneca
2023年1月11日 · Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.
AIRSUPRA® - AstraZeneca US
AIRSUPRA (albuterol sulfate and budesonide) Jump To Highlights of Prescribing Information
AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg) Inhalation …
AIRSUPRA contains both albuterol (a SABA) and budesonide (an inhaled corticosteroid, or ICS) to help address both. Find out more AIRSUPRA is the only asthma rescue inhaler FDA-approved to treat symptoms and help prevent asthma attacks*
Anti-Inflammatory Asthma Rescue | AIRSUPRA Inhalation Aerosol …
Learn how AIRSUPRA® (mabuterol 90 mcg/budesonide 80 mcg), an asthma rescue inhaler, treats bronchoconstriction and reduces the risk of exacerbations in adults.
Fixed-dose combination of albuterol and budesonide (PT027 ... - AstraZeneca
2021年9月9日 · It is an inhaled, fixed-dose combination of albuterol (also known as salbutamol), a SABA, and budesonide, a corticosteroid, and is being developed in a pMDI using AstraZeneca’s Aerosphere delivery technology.
First time an albuterol/budesonide fixed-dose combination ... - AstraZeneca
2022年5月15日 · PT027 is a potential first-in-class inhaled, fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide in the US. It is being developed by AstraZeneca and Avillion.
跳至内容